Article: FDA issues approvable letter for AMBIEN CR CIV for the treatment of insomnia.(Industry News)

Sanofi-aventis recently announced that it had received an approvable letter from the FDA for AMBIEN CR (zolpidem tartrate extended release) CIV. AMBIEN CR[TM] is the controlled-release formulation of zolpidem, a leading sleep aid.

An approvable letter outlines specific questions that have to be ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!